ANIP 8-K 2026-11-05

ANI PHARMACEUTICALS INC (ANIP) 8-K dated 2026-11-05 — accession 0001023024-26-000077.

ANI PHARMACEUTICALS INC (ANIP) is a drug manufacturers - specialty & generic company listed on US.

ANI PHARMACEUTICALS INC filed a 8-K on 2026-11-05. Accession 0001023024-26-000077.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ANIP revenue for 2025-12-31 was $883.4M. Net income was $78.3M. Revenue was up 43.8% from 2024-12-31 to 2025-12-31. ANIP currently screens at market cap $1.41B and trailing P/E 14.0.

Not investment advice. The ANIP SEC hub lists recent forms. The stock page is the research view.